U.S. PHARMACOPEIA

Search USP29  
Metformin Hydrochloride
Click to View Image
C4H11N5·HCl 165.62

Imidodicarbonimidic diamide, N,N-dimethyl-, monohydrochloride.
1,1-Dimethylbiguanide monohydrochloride [1115-70-4].
» Metformin Hydrochloride contains not less than 98.5 percent and not more than 101.0 percent of C4H11N5·HCl, calculated on the dried basis.
Add the following:
Packaging and storage— Preserve in well-closed containers. Store at room temperature.USP29
USP Reference standards 11 USP Metformin Hydrochloride RS. USP Metformin Related Compound A RS.
Identification—
A: Infrared Absorption 197K.
B: It meets the requirements of the tests for Chloride 191.
Loss on drying 731 Dry it at 105 for 5 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.1%.
Related compounds—
Mobile phase— Prepare a solution in water, containing 17 g of monobasic ammonium phosphate per L, adjust with phosphoric acid to a pH of 3.0, and mix.
Standard solution—
Prepare a solution of USP Metformin Related Compound A RS in water having a known concentration of about 0.2 mg per mL. Transfer 1.0 mL of this solution to a 200-mL volumetric flask, dilute with Mobile phase to volume, and mix. [NOTE—Metformin related compound A is 1-cyanoguanidine.]
Test solution— Transfer about 500 mg of Metformin Hydrochloride, accurately weighed, to a 100-mL volumetric flask, dissolve in and dilute with Mobile phase to volume, and mix.
Diluted test solution— Transfer 1.0 mL of the Test solution to a 10-mL volumetric flask, dilute with Mobile phase to volume, and mix. Transfer 1.0 mL of this solution to a 100-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Resolution solution— Transfer about 10 mg of melamine to a 100-mL volumetric flask, and dissolve in about 90 mL of water. Add 5.0 mL of the Test solution, dilute with water to volume, and mix. Transfer 1.0 mL of this solution to a 50-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 218-nm detector and a 4.6-mm × 25-cm column containing packing L9. The flow rate is about 1.0 to 1.7 mL per minute. Chromatograph the Resolution solution, and record the peak responses as directed for Procedure: the resolution, R, between melamine and metformin is not less than 10.
Procedure— Separately inject equal volumes (about 20 µL) of the Test solution, the Standard solution, and the Diluted test solution into the chromatograph, record the chromatograms for not less than twice the retention time of metformin, and measure the peak areas. The area of a peak corresponding to metformin related compound A in the chromatogram of the Test solution is not greater than the area of the corresponding peak in the chromatogram of the Standard solution: not more than 0.02% of metformin related compound A is found.
The area of any other secondary peak in the chromatogram of the Test solution is not greater than the area of the major peak in the chromatogram of the Diluted test solution; and the sum of the areas of all secondary peaks in the chromatogram of the Test solution is not greater than five times the area of the major peak in the chromatogram of the Diluted test solution: not more than 0.1% of any other impurity is found; and not more than 0.5% of total impurities is found.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay— [NOTE—To avoid overheating of the reaction medium, mix thoroughly throughout the titration, and stop the titration immediately after the endpoint has been reached.] Dissolve about 60 mg of Metformin Hydrochloride, accurately weighed, in 4 mL of anhydrous formic acid. Add 50 mL of acetic anhydride. Titrate with 0.1 N perchloric acid VS, determining the endpoint potentiometrically. Perform a blank determination, and make any necessary correction (see Titrimetry 541). Each mL of 0.1 N perchloric acid is equivalent to 8.28 mg of C4H11N5·HCl.
Auxiliary Information— Staff Liaison : Elena Gonikberg, Ph.D., Scientist
Expert Committee : (MDGRE05) Monograph Development-Gastrointestinal Renal and Endocrine
USP29–NF24 Page 1364
Pharmacopeial Forum : Volume No. 31(4) Page 1092
Phone Number : 1-301-816-8251